Real-life dosing with second-generation antipsychotics. [electronic resource]
Producer: 20060301Description: 1610-1 p. digitalISSN:- 0160-6689
- Antipsychotic Agents -- administration & dosage
- Clinical Trials, Phase IV as Topic
- Drug Administration Schedule
- Drug Approval
- Humans
- Maximum Tolerated Dose
- Product Surveillance, Postmarketing
- Psychotic Disorders -- drug therapy
- Randomized Controlled Trials as Topic
- Schizophrenia -- drug therapy
- Schizophrenic Psychology
- Treatment Outcome
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.